Microbix Announces Quality Products Distribution Agreement

    NEXT STORY
    Theratechnologies Announces New Positive Results for two Investigational Peptide-Drug Conjugates Targeting Sortilin Positive Ovarian Cancer
    PREV STORY
    Sanofi and Regeneron provide update on U.S. Phase 2/3 adaptive-designed trial in hospitalized COVID-19 patients
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Great Basin Scientific Granted U.S. Patent for PCR Amplification Suppressor

    SALT LAKE CITY, Nov. 29, 2016 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), ...

    author_avatar
    NASDAQ Market News

    BeyondSpring Announces Positive Topline Interim Results from PROTECTIVE-2 (Study 106) Phase 3 Trial Evaluating Superiority of Plinabulin in Combination with Neulasta for Chemotherapy-Induced Neutropenia Prevention

    author_avatar
    NASDAQ Market News

    Onconova Therapeutics to Present at the Disruptive Growth and Healthcare Conference on May 8th, 2018

    NEWTOWN, Pa., May 03, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase ...

    author_avatar
    NASDAQ Market News